Evidence map›Paper›PMID 29594923›Full record

Trial reportInternational journal of hematology2018

Perioperative safety and hemostatic efficacy of Advate

Keiji Nogami, Hideyuki Takedani, Midori Shima, Akira Yoshioka, Tadashi Matsushita, Junki Takamatsu, Masashi Taki, Katsuyuki Fukutake, Haruhiko Uchikawa, Hiroshi Takagi and 3 more

Abstract readClinical TrialMulticenter Study
PubMed Publisher
In one paragraph

Trial report in International journal of hematology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Inhibitor development, safety, and efficacy of AdvateInternational journal of hematology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 1 country.

Keiji NogamiDepartment of Pediatrics, Nara Medical University, Kashihara, Japan. roc-noga@naramed-u.ac.jp.
Hideyuki TakedaniDepartment of Joint Surgery, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Midori ShimaDepartment of Pediatrics, Nara Medical University, Kashihara, Japan.
Akira YoshiokaDepartment of Pediatrics, Nara Medical University, Kashihara, Japan.
Tadashi MatsushitaDepartment of Transfusion Medicine, Nagoya University Hospital, Nagoya, Japan.
Junki TakamatsuJapanese Red Cross Tokai-Hokuriku Block Blood Center, Seto, Japan.
Masashi TakiDepartment of Pediatrics, St. Marianna University School of Medicine Yokohama City Seibu Hospital, Yokohama, Japan.
Katsuyuki FukutakeDepartment of Laboratory Medicine, Tokyo Medical University Hospital, Tokyo, Japan.
Haruhiko UchikawaDepartment of Clinical Scientific Writing, Clinical Development Operations, Shire Japan K.K., Tokyo, Japan.
Hiroshi TakagiDepartment of Medical Affairs, Shire Japan K.K., Tokyo, Japan.
Morio AraiDepartment of Medical Affairs, Shire Japan K.K., Tokyo, Japan.
Werner EnglDepartment of Biostatistics, Baxalta Innovations GmbH, Vienna, Austria.
Akira ShirahataKitakyushu Yahata Higashi Hospital, Kitakyushu, Japan.
Nara Medical University · JPJapanese Red Cross Society, Japan · JPKitakyushu City Yahata Hospital · JPNagoya University Hospital · JPSt. Marianna University School of Medicine · JPThe University of Tokyo · JPTokyo Medical University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rurioctocog alfa (recombinant factor VIII: Advate

Indexed as

Product Surveillance, PostmarketingAdolescentAdultAgedChildChild, PreschoolFactor VIIIFemaleHemophilia AHemostaticsHumansInfantInfusions, IntravenousJapanMaleMiddle AgedFactor VIIIHemostaticsRecombinant ProteinsAdvate®Hemophilia APostmarketing surveillanceRecombinant factor VIIISurgery

Identifiers

PMID29594923
OpenAlexW2794877950

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.